These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31995008)

  • 1. 4-Oxoquinoline Derivatives as Antivirals: A Ten Years Overview.
    Batalha PN; da S M Forezi L; Tolentino NMC; Sagrillo FS; de Oliveira VG; de Souza MCBV; da C S Boechat F
    Curr Top Med Chem; 2020; 20(3):244-255. PubMed ID: 31995008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure Properties and Mechanisms of Action of Naturally Originated Phenolic Acids and Their Derivatives against Human Viral Infections.
    Wu YH; Zhang BY; Qiu LP; Guan RF; Ye ZH; Yu XP
    Curr Med Chem; 2017; 24(38):4279-4302. PubMed ID: 28814240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiosemicarbazides: Updates on Antivirals Strategy.
    Moharana AK; Dash RN; Subudhi BB
    Mini Rev Med Chem; 2020; 20(20):2135-2152. PubMed ID: 32811412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiphage activity of natural and synthetic substances: a new age for antivirals?
    Ribeiro JM; Pereira GN; Kobayashi RK; Nakazato G
    Future Microbiol; 2020 Jun; 15():767-777. PubMed ID: 32700548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antivirals of ethnomedicinal origin: structure-activity relationship and scope.
    Chattopadhyay D; Naik TN
    Mini Rev Med Chem; 2007 Mar; 7(3):275-301. PubMed ID: 17346219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and photodynamic effects of new porphyrin/4-oxoquinoline derivatives in the inactivation of S. aureus.
    Sagrillo FS; Dias C; Gomes ATPC; Faustino MAF; Almeida A; Gonçalves de Souza A; Costa ARP; Boechat FDCS; Bastos Vieira de Souza MC; Neves MGPMS; Cavaleiro JAS
    Photochem Photobiol Sci; 2019 Aug; 18(8):1910-1922. PubMed ID: 31328761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-Quinolone derivatives and their activities against Gram positive pathogens.
    Zhang GF; Zhang S; Pan B; Liu X; Feng LS
    Eur J Med Chem; 2018 Jan; 143():710-723. PubMed ID: 29220792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral activity of 4-oxoquinoline-3-carboxamide derivatives against bovine herpesvirus type 5.
    Pinto AMV; Leite JPG; Marinho RS; Forezi LDS; Batalha PN; Boechat FDC; Cunha AC; Silva DO; Gama IL; Faro LV; de Souza MC; Paixão ICP
    Antivir Ther; 2020; 25(1):13-20. PubMed ID: 31538962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plant and animal steroids a new hope to search for antiviral agents.
    Castilla V; Ramírez J; Coto CE
    Curr Med Chem; 2010; 17(18):1858-73. PubMed ID: 20377516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural biology in antiviral drug discovery.
    Bassetto M; Massarotti A; Coluccia A; Brancale A
    Curr Opin Pharmacol; 2016 Oct; 30():116-130. PubMed ID: 27611878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Antiviral Action of Alkaloids.
    Abookleesh FL; Al-Anzi BS; Ullah A
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antivirals against animal viruses.
    Villa TG; Feijoo-Siota L; Rama JLR; Ageitos JM
    Biochem Pharmacol; 2017 Jun; 133():97-116. PubMed ID: 27697545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic Compounds with 2-Amino-1,3,4-Thiadiazole Moiety Against Viral Infections.
    Serban G
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32093125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the antiviral potential of pyrrole-imidazole polyamides?
    He G; Bashkin JK
    Future Med Chem; 2015; 7(15):1953-5. PubMed ID: 26496156
    [No Abstract]   [Full Text] [Related]  

  • 15. 1,3,4-oxadiazole: a privileged structure in antiviral agents.
    Li Z; Zhan P; Liu X
    Mini Rev Med Chem; 2011 Nov; 11(13):1130-42. PubMed ID: 22353222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbazole Derivatives as Antiviral Agents: An Overview.
    Caruso A; Ceramella J; Iacopetta D; Saturnino C; Mauro MV; Bruno R; Aquaro S; Sinicropi MS
    Molecules; 2019 May; 24(10):. PubMed ID: 31109016
    [No Abstract]   [Full Text] [Related]  

  • 17. Human viral diseases: what is next for antiviral drug discovery?
    De Clercq E
    Curr Opin Virol; 2012 Oct; 2(5):572-9. PubMed ID: 22846888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial overview: antivirals and resistance: advances and challenges ahead.
    Menéndez-Arias L; Richman DD
    Curr Opin Virol; 2014 Oct; 8():iv-vii. PubMed ID: 25155454
    [No Abstract]   [Full Text] [Related]  

  • 19. Antivirals and antiviral strategies.
    De Clercq E
    Nat Rev Microbiol; 2004 Sep; 2(9):704-20. PubMed ID: 15372081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug Repurposing for Viral Infectious Diseases: How Far Are We?
    Mercorelli B; Palù G; Loregian A
    Trends Microbiol; 2018 Oct; 26(10):865-876. PubMed ID: 29759926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.